US 7501494
Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
granted A61KA61K2039/505A61P
Quick answer
US patent 7501494 (Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection) held by United Biomedical, Inc. expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Biomedical, Inc.
- Grant date
- Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/18, A61P37/02